January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced today a partnership with Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical [...]
More news
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) and BIOASTER, the [...]
The Entrepreneurs Club is back! Join this 3rd INCATE Entrepreneurs Club on "Creative Funding - [...]
Nijmegen, 12th September 2023 - By the occasion of the World Sepsis Day, SurvivX is [...]
The next INCATE's Selection Committee is coming up and we are now accepting applications for [...]
2023 has reached its final quarter and there are still quite a number of events [...]
6th September 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) has successfully reached [...]
INCATE PRESS RELEASE 08, May 2023 For immediate release INCATE has selected Invitris as the [...]
All photographs - Copyright - eventfotografen.com/bamconn GmbH The AMR-Conference, Europe’s leading conference on the antibiotic [...]
